Taste and Smell Disorders in COVID-19 Patients at a Local Healthcare Trust in Northern Italy: a CrossSectional Study

Taste and Smell Disorders in COVID-19 Patients at a Local Healthcare Trust in Northern Italy: a CrossSectional Study

Authors

  • N. Piu
  • A. Isabella
  • C. Airoldi
  • C. Aleni
  • A. Sarro
  • F. Faggiano

Keywords:

Covid-19, Loss of smell, Loss of taste, Severity of disease

Abstract

Background. In Italy, since the beginning of the COVID-19 pandemic, patients testing positive for SARSCoV-2 through nasopharyngeal swab have reported taste and smell alterations. As these symptoms are quite uncommon in other respiratory infections, their specificity and prevalence are useful features for the differential diagnosis of COVID-19.

The objective was to describe taste and smell alterations in patients diagnosed with SARS-CoV-2 infection and to define the onset of those disorders during the clinical course of the disease.

Study design. Cross-sectional study.

Methods. This study was conducted on adult patients testing positive for SARS-CoV-2 infection through nasopharyngeal swab at a Local Healthcare Trust in Northern Italy between April 27th and May 27th, 2020. In order to investigate the clinical course, the onset of the first symptoms, smell and/or taste alterations, a phonebased questionnaire was administered during the programming of the second nasopharyngeal swab.

Results. We recruited 168 patients; the mean age was 52 years old, and 94 (56.0%) were female. Among the 135 symptomatic patients, 87 (64.4%) reported taste and smell alterations. Patients with a mild clinical course showed the highest prevalence for taste and smell disorders (76.6%), which were also associated with a more benign clinical course of the disease (P = 0.0166). Furthermore, in 33 (37.9%) of these patients, changes in smell and taste perception appeared before the acute phase of the disease. Among the 14 patients with a severe clinical course of SARS-CoV-2 infection, 8 reported a variation of taste and smell perception before the hospitalization, with a median of 4 days (IQR 2-7)

Conclusions. Smell and taste disorders can be listed among the first symptoms of SARS-CoV-2 infection and may anticipate the acute phase of the disease. Noteworthy, they seem to be associated with a more benign clinical course.

References

1. Ottaviano G, Carecchio M, Scarpa B, MarcheseRagona R. Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss 2020. Rhinology 2020 Aug 1; 58(4): 400-1. doi: 10.4193/Rhin20.136. Epub 2020 Apr 27.

2. Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.

J Infect 2020 Jun; 80(6): 656-65. doi: 10.1016/j. jinf.2020.03.041. Epub 2020 Apr 10.

3. Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARSCoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One 2020 June 23; 15(6): e0234765. doi: 10.1371/journal.pone.0234765.

4. Paderno A, Mattavelli D, Rampinelli V, et al.

Olfactory and Gustatory Outcomes in COVID19: A Prospective Evaluation in Nonhospitalized Subjects. Otolaryngol Head Neck Surg 2020 Dec; 163(6): 1144-9. doi: 10.1177/0194599820939538. Epub 2020 Jun 30.

5. Salmon D, Bartier S, Hautefort C, et al. Selfreported loss of smell without nasal obstruction to identify COVID-19. The multicenter CORANOSMIA cohort study. J Infect 2020 Oct; 81(4): 614-20. doi: 10.1016/j.jinf.2020.07.005. Epub 2020 Jul 7.

6. World Health Organization (WHO). Clinical Management of Covid-19. May 27, 2020. Available on: https://www.euro.who.int/en/health-topics/ health-emergencies/coronavirus-covid-19/publications-and-technical-guidance/2020/clinicalmanagement-of-covid-19-interim-guidance,-27 -may-2020 [Last accessed: 2021 Mar 16].

7. Kanjanaumporn J, Aeumjaturapat S, Snidvongs K, Seresirikachorn K, Chusakul S. Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options. Asian Pac J Allergy Immunol 2020 Jun; 38(2): 69-77. doi: 10.12932/AP-030520-0826.

8. Wong DKC, Gendeh HS, Thong HK, et al. A review of smell and taste dysfunction in COVID19 patients. Med J Malaysia 2020 Sep; 75(5): 574-81.

9. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg 2020 Jul; 163(1): 3-11. doi:

10.1177/0194599820926473. Epub 2020 May 5.

10. Printza A, Constantinidis J. The role of selfreported smell and taste disorders in suspected COVID-19. Eur Arch Otorhinolaryngol 2020 Sep; 277(9): 2625-30. doi: 10.1007/s00405-020 -06069-6. Epub 2020 May 23.

11. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020 Aug; 277(8): 2251-61. doi: 10.1007/ s00405-020-05965-1. Epub 2020 Apr 6.

12. Foster KJ, Jauregui E, Tajudeen B, Bishehsari F, Mahdavinia M. Smell loss is a prognostic factor for lower severity of coronavirus disease 2019. Ann Allergy Asthma Immunol 2020 Oct; 125(4): 481-3. doi: 10.1016/j.anai.2020.07.023.

Epub 2020 Jun 24.

Downloads

Published

2025-09-04

Issue

Section

Original research

How to Cite

1.
Piu N, Isabella A, Airoldi C, Aleni C, Sarro A, Faggiano F. Taste and Smell Disorders in COVID-19 Patients at a Local Healthcare Trust in Northern Italy: a CrossSectional Study . Ann Ig. 2025;34(2):122-127. doi:10.7416/ai.2022.2474